MedPath
FDA Approval

Orphenadrine Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 4, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Orphenadrine(100 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Orphenadrine Citrate

Product Details

NDC Product Code
33261-088
Application Number
ANDA040284
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 4, 2012
Code: X0A40N8I4SClass: ACTIBQuantity: 100 mg in 1 1
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath